Financials Nova Wellness Group

Equities

End-of-day quote BURSA MALAYSIA Other stock markets 23:00:00 28/04/2024 BST			5-day change	1st Jan Change
0.525 ^MYR	+0.96%		+0.96%	-15.32%

02-20	Nova Wellness Group Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Nova Wellness' Profit, Revenue Drop in Fiscal Q1	MT

Fiscal Period: June	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	203.4	271.7	279.7	219.9	165.7	-	-
Enterprise Value (EV) ¹	203.4	271.7	259.3	219.9	165.7	165.7	165.7
P/E ratio	15.6 x	18.7 x	17.6 x	14.6 x	11.5 x	10.2 x	8.33 x
Yield	-	-	2.33%	3.04%	5.02%	5.46%	7.81%
Capitalization / Revenue	-	6.71 x	5.69 x	4.83 x	3.62 x	3.29 x	2.92 x
EV / Revenue	-	6.71 x	5.69 x	4.83 x	3.62 x	3.29 x	2.92 x
EV / EBITDA	-	13.3 x	12.3 x	10.9 x	7.92 x	7.03 x	6.05 x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Price to Book	-	2.85 x	2.75 x	2.09 x	1.46 x	1.35 x	-
Nbr of stocks (in thousands)	317,744	317,744	317,794	318,720	318,720	-	-
Reference price ²	0.6400	0.8550	0.8800	0.6900	0.5250	0.5250	0.5250
Announcement Date	18/08/20	09/09/21	25/08/22	18/08/23	-	-	-

¹MYR in Million²MYR

Estimates

Fiscal Period: June	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	40.48	49.14	45.53	45.8	50.4	56.8
EBITDA ¹	-	20.4	22.69	20.17	20.93	23.57	27.4
EBIT ¹	-	19.29	-	17.84	16.6	18	-
Operating Margin	-	47.65%	-	39.18%	36.24%	35.71%	-
Earnings before Tax (EBT) ¹	-	19.29	20.1	19.76	18.97	21.47	26.2
Net income ¹	13	14.56	15.92	14.99	14.57	16.47	20
Net margin	-	35.96%	32.41%	32.93%	31.8%	32.67%	35.21%
EPS ²	0.0409	0.0458	0.0501	0.0472	0.0457	0.0517	0.0630
Free Cash Flow	-	-	-	-	-	-	-
FCF margin	-	-	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-
Dividend per Share ²	-	-	0.0205	0.0210	0.0263	0.0287	0.0410
Announcement Date	18/08/20	09/09/21	25/08/22	18/08/23	-	-	-

¹MYR in Million²MYR

Estimates

Fiscal Period: June	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-
Net Cash position	-	-	20.4	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-	-
ROE (net income / shareholders' equity)	-	16.1%	16.4%	14.5%	14%	14.5%	18.5%
ROA (Net income/ Total Assets)	-	14.5%	14.7%	13.1%	10.2%	9.9%	-
Assets ¹	-	100.4	108.4	114.6	142.8	166.3	-
Book Value Per Share ²	-	0.3000	0.3200	0.3300	0.3600	0.3900	-
Cash Flow per Share	-	-	-	-	-	-	-
Capex ¹	-	5.45	-	9.32	8.8	6.4	-
Capex / Sales	-	13.47%	-	20.47%	19.21%	12.7%	-
Announcement Date	18/08/20	09/09/21	25/08/22	18/08/23	-	-	-

¹MYR in Million²MYR

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

C-

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.525 MYR

Average target price

0.6633 MYR

Spread / Average Target

+26.35%

	1st Jan change	Capi.
NOVA WELLNESS GROUP	-15.32%	34.76M
ZHEJIANG NHU COMPANY LTD.	+11.32%	7.78B
BELLRING BRANDS, INC.	+1.64%	7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.50%	6.52B
BYHEALTH CO., LTD	-6.69%	3.67B
THE SIMPLY GOOD FOODS COMPANY	-13.51%	3.44B
XIAMEN KINGDOMWAY GROUP COMPANY	-10.10%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-41.81%	879M
USANA HEALTH SCIENCES, INC.	-19.81%	836M